Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-25-022140
Filing Date
2025-11-13
Accepted
2025-11-13 09:05:39
Documents
16
Effectiveness Date
2025-11-13

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 79720
2 EX-5.1 ex5-1.htm EX-5.1 13747
3 EX-23.1 ex23-1.htm EX-23.1 4715
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 29657
5 GRAPHIC ex5-1_001.jpg GRAPHIC 7994
6 GRAPHIC ex5-1_002.jpg GRAPHIC 7486
  Complete submission text file 0001493152-25-022140.txt   271409

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5534
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-291493 | Film No.: 251475744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)